These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35164657)

  • 1. Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro.
    Ji J; Feng M; Huang Y; Niu X
    Bioengineered; 2022 Mar; 13(3):5091-5102. PubMed ID: 35164657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways.
    Luo Y; Yang P; Li Z; Luo Y; Shen J; Li R; Zheng H; Liang Y; Xia N
    Drug Des Devel Ther; 2019; 13():4065-4074. PubMed ID: 31819375
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lee JA; Gu MJ; Lee YR; Kim Y; Choi I; Kim D; Ha SK
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.
    Jiang JX; Chen X; Fukada H; Serizawa N; Devaraj S; Török NJ
    Hepatology; 2013 Oct; 58(4):1339-48. PubMed ID: 23703665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
    Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
    Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
    Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
    J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
    Li P; Tang Z; Wang L; Feng B
    Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.
    Matsumoto M; Zhang J; Zhang X; Liu J; Jiang JX; Yamaguchi K; Taruno A; Katsuyama M; Iwata K; Ibi M; Cui W; Matsuno K; Marunaka Y; Itoh Y; Torok NJ; Yabe-Nishimura C
    Free Radic Biol Med; 2018 Feb; 115():412-420. PubMed ID: 29274380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
    Paik YH; Iwaisako K; Seki E; Inokuchi S; Schnabl B; Osterreicher CH; Kisseleva T; Brenner DA
    Hepatology; 2011 May; 53(5):1730-41. PubMed ID: 21384410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation.
    Zhang H; Chu Y; Zheng H; Wang J; Song B; Sun Y
    Aging (Albany NY); 2020 Nov; 13(1):525-536. PubMed ID: 33298623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 plays a key role in advanced glycation end products-induced M1 macrophage polarization.
    Liu Z; Ma Y; Cui Q; Xu J; Tang Z; Wang Y; He C; Wang X
    Biochem Biophys Res Commun; 2020 Oct; 531(4):602-608. PubMed ID: 32814631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Ramos IP; da Silva IJ; Machado MP; Miranda RA; Pazos-Moura CC; Gonçalves-de-Albuquerque CF; Faria-Neto HCC; Tibiriça E; Daliry A
    PLoS One; 2017; 12(6):e0179654. PubMed ID: 28628674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer.
    Petriv N; Neubert L; Vatashchuk M; Timrott K; Suo H; Hochnadel I; Huber R; Petzold C; Hrushchenko A; Yatsenko AS; Shcherbata HR; Wedemeyer H; Lichtinghagen R; Falfushynska H; Lushchak V; Manns MP; Bantel H; Semchyshyn H; Yevsa T
    Oncoimmunology; 2021 Feb; 10(1):1874159. PubMed ID: 33628620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway.
    Li Z; Feng PP; Zhao ZB; Zhu W; Gong JP; Du HM
    Biochem Biophys Res Commun; 2019 Feb; 510(1):20-26. PubMed ID: 30683312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
    Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
    FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idebenone reduces sepsis-induced oxidative stress and apoptosis in hepatocytes via RAGE/p38 signaling.
    Gou T; Jin X; Xia J
    Ann Transl Med; 2022 Dec; 10(24):1363. PubMed ID: 36660726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease].
    Gao H; Xu L; Li D; Guang L; Deng W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1661-4. PubMed ID: 24273273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.